One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Pros and cons of the use of fluoroquinolone antibiotics in patients with kidney diseaseÂ
Fatemeh Ahmadi, Y Joseph Hwang, Flory T Muanda
doi : 10.1093/ndt/gfae037
Volume 39, Issue 8, August 2024
The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseasesÂ
Giorgio Trivioli, Francesco Peyronel, Augusto Vaglio
doi : 10.1093/ndt/gfad265
Capillary rarefication as a possible cause of long-COVID syndromeÂ
Irina Osiaevi, Philipp Kümpers, Julia Weinmann-Menke, Hermann Pavenstädt, Alexandros Rovas
doi : 10.1093/ndt/gfae026
Facts and myths about altruistic organ donationÂ
Mehmet Sukru Sever, Thomas F Mueller, Gabriel C Oniscu, Paolo Schena, Raymond VanholderÂ
doi : 10.1093/ndt/gfae039
Glomerular hyperfiltration as a therapeutic target for CKD
Mehmet Kanbay, Sidar Copur, Cicek N Bakir, Adrian Covic, Alberto Ortiz, Katherine R Tuttle
doi : 10.1093/ndt/gfae027
Alkaline phosphatase treatment of acute kidney injury—an updateÂ
Thei S Steenvoorden, Janneke A J Rood, Frederike J Bemelman, Roberto Armstrong Jr., Henri G D Leuvenink, Joost W van der Heijden, Liffert Vogt
doi : 10.1093/ndt/gfae028
Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillationÂ
Simonetta Genovesi, A John Camm, Adrian Covic, Alexandru Burlacu, Björn Meijers, Casper Franssen, Valerie Luyckx, Vassilios Liakopoulos, Gaetano Alfano, Christian Combe, Carlo Basile
doi : 10.1093/ndt/gfae121
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient careÂ
Maria K Svensson, Toyoaki Murohara, Eva Lesén, Matthew Arnold, Thomas Cars, Krister Järbrink, Gengshi Chen, Naru Morita, Sudhir Venkatesan, Eiichiro Kanda
doi : 10.1093/ndt/gfae016
Global, regional and national burden of CKD in children and adolescents from 1990 to 2019
Wen-Man Zhao, Xun-Liang Li, Rui Shi, Yuyu Zhu, Zhi-Juan Wang, Xue-Rong Wang, Hai-Feng Pan, De-Guang Wang
doi : 10.1093/ndt/gfad269
Association between urinary C4d levels and disease progression in IgA nephropathyÂ
Yaping Dong, Zi Wang, Weiyi Guo, Li Zhu, Xujie Zhou, Sufang Shi, Lijun Liu, Jicheng Lv, Hong Zhang
doi : 10.1093/ndt/gfae001
Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome
Teresa Bada-Bosch, Angel M Sevillano, MarÃa Teresa Sánchez-Calvin, Carmen Palma-Milla, Ignacio Alba de Cáceres, Francisco DÃaz-Crespo, Hernando Trujillo, Marina Alonso, Clara Cases-Corona, Amir Shabaka, Juan Francisco Quesada-Espinosa, José Miguel Lezana-Rosales, Eduardo Gutiérrez, Gema Fernández-Juárez, Fernando Caravaca-Fontán, Manuel Praga
doi : 10.1093/ndt/gfae002
Outcome of immunosuppression in children with IgA vasculitis–related nephritis
Katharina Rohner, Matko Marlais, Yo Han Ahn, Alaa Ali, Abrar Alsharief, Anja Blejc Novak, Marta Brambilla, Evrim Kargin Cakici, Cengiz Candan, Nur Canpolat, Eugene Yu-hin Chan, Stéphane Decramer, Madeleine Didsbury, Filipa Durao, Anne M Durkan, Ali Düzova, Thomas Forbes, Valentina Gracchi, Tulin Güngör, Tomoko Horinouchi, Belde Kasap Demir, Yasuko Kobayashi, Mikael Koskela, Eda Didem Kurt-Sukur, Claudio La Scola, Dean Langan, Xiaozhong Li, Gabriele Malgieri, Antonio Mastrangelo, Jeesu Min, Malgorzata Mizerska-Wasiak, Nabila Moussaoui, Aytul Noyan, Matti Nuutinen, Jennifer O'Gormon, Takayuki Okamoto, Louise Oni, Michiel Oosterveld, Malgorzata Pańczyk-Tomaszewska, Gonul Parmaksiz, Andrea Pasini, Pornpimol Rianthavorn, Joris Roelofs, Yunyan Shen, Rajiv Sinha, Rezan Topaloglu, Diletta Domenica Torres, Tomohiro Udagawa, Martin Wennerström, Yok Chin Yap, Kjell Tullus
doi : 10.1093/ndt/gfae009
Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers and health professionals
Andrea Matus Gonzalez, Nicole Evangelidis, Martin Howell, Allison Jaure, Benedicte Sautenet, Magdalena Madero, Gloria Ashuntantang, Samaya Anumudu, Amelie Bernier-Jean, Louese Dunn, Yeoungjee Cho, Laura Cortes Sanabria, Ian H de Boer, Samuel Fung, Daniel Gallego, Chandana Guha, Andrew S Levey, Adeera Levin, Eduardo Lorca, Ikechi G Okpechi, Patrick Rossignol, Nicole Scholes-Robertson, Laura Sola, Armando Teixeira-Pinto, Tim Usherwood, Andrea K Viecelli, David C Wheeler, Katherine Widders, Martin Wilkie, Jonathan C Craig
doi : 10.1093/ndt/gfae010
Diabetes mellitus: association of cystatin C- versus creatinine-based estimated glomerular filtration rate with mortality and cardiovascular events
Daijun He, Bixia Gao, Jinwei Wang, Chao Yang, Shouling Wu, Shuohua Chen, Junjuan Li, Min Chen, Ming-Hui Zhao, Luxia Zhang
doi : 10.1093/ndt/gfae011
Gut flora metagenomic analysis coupled with metabolic and deep immune profiling in chronic kidney disease
I-Wen Wu, Lun-Ching Chang, Yi-Lun Wu, Huang-Yu Yang, Yuh-Ching Twu, Po-Yu Tsai, Skyler Paulus, Rhian Resnick, Wen-Hung Chung, Chih-Wei Yang, Wen-Ping Hsieh, Shih-Chi Su
doi : 10.1093/ndt/gfae013
GSDMD and GSDME synergy in the transition of acute kidney injury to chronic kidney disease
Zhengyue Chen, Caiming Chen, Kunmei Lai, Chengkun Wu, Fan Wu, Zhimin Chen, Keng Ye, Jingzhi Xie, Huabin Ma, Hong Chen, Yujia Wang, Yanfang Xu
doi : 10.1093/ndt/gfae014
Long-term kidney function of Lowe syndrome: a nationwide study of paediatric and adult patients
Taro Ando, Kenichiro Miura, Tomoo Yabuuchi, Yoko Shirai, Kiyonobu Ishizuka, Shoichiro Kanda, Yutaka Harita, Kyoko Hirasawa, Riku Hamada, Kenji Ishikura, Eisuke Inoue, Motoshi Hattori
doi : 10.1093/ndt/gfae080
Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults
Li Jin, Xueying Liu, Huixian Li, Xiangyun Dang, Zhigang Wang, Dan Niu, Xiaotian Zhang, Jiping Sun, Dapeng Hao, Wanhong Lu
doi : 10.1093/ndt/gfae061
Effects of HIF-PHD inhibitors in kidney development
Soichiro Haraguchi, Kenji Tsuji, Hiroyuki Nakanoh, Kazuhiko Fukushima, Shinji Kitamura, Jun Wada
doi : 10.1093/ndt/gfae078
